Decision Resources, Inc., Feb 2008, Pages: 74
of the most attractive features of the U.S. market for pharmaceutical companies is the unrivalled freedom of its pricing and reimbursement environment. How has the Deficit Reduction Act of 2005, in effect since
GBI Research, Feb 2012, Pages: 75
, information and analysis of pricing and reimbursement decisions across the US. The report closely scrutinizes major changes in pharmaceuticals-related pricing and reimbursement in the US in the recent past
IMS Health, Jan 2007, Pages: 380
-Japan
-Netherlands
-New Zealand
-Norway
-Poland
-Portugal
-South Africa
-Spain
-Sweden
-Switzerland
-United Kingdom
-United States of America IMS PharmaceuticalPharmaceuticalPricing and Reimbursement
Decision Resources, Inc., June 2011
of the Healthcare System
Regulatory Reform and Intellectual Property Protection
PharmaceuticalPricing and Reimbursement
Historical Pricing Procedure
Current Pricing Procedures
Admission to Reimbursement
Decision Resources, Inc., Oct 2011
, and the United Kingdom plans to introduce major reforms in January 2014.
Questions answered in this report:
- The EU Transparency Directive states that pharmaceuticalpricing procedures must be completed within 90 days
Decision Resources, Inc., Aug 2011 pharmaceutical markets (United States, France, Germany, Italy, Spain, United Kingdom, and Japan) will grow from 19 million in 2010 to 20.7 million in 2020, an increase of 9% in ten years. Many of these patients
Decision Resources, Inc., May 2011
systems in the longer term. Politicians in the United States clashed over proposals for healthcare reform, while the European Union launched a consultation on drug pricing and reimbursement.
Questions
Decision Resources, Inc., Oct 2011
and reimbursement landscape for respiratory drug therapies.
Exhibits: 33 tables and figures showing comparative drug prices, respiratory disease epidemiology, market data, healthcare system characteristics, U.S.
Decision Resources, Inc., Dec 2009, Pages: 58
for the Pharmaceutical Industry
Tables
1. Ex-Manufacturer Prices of Select Targeted Cancer Therapies in Europe and Japan as a Percentage of U.S.Prices, 2008
2. U.S. Commercial Health Plans’ Formulary Positioning
Decision Resources, Inc., Dec 2009, Pages: 27
when a price is deemed excessive?
- Canada’s brand-name drug prices tend to be well below U.S.prices. For many years, U.S. legislators have debated the issue of cross-border trade of pharmaceuticals
Decision Resources, Inc., March 2011, Pages: 70
in this report:
- The United States has the highest overall prescription drug prices of any of the major pharmaceutical markets. How do the prices of metabolic disease therapies in Europe and Japan compare
Decision Resources, Inc., April 2011, Pages: 40
)
- U.S. Census Bureau The Evolving Hospital Reimbursement Environment Presents New Challenges for the Pharmaceutical Industry
Decision Resources, Inc., Dec 2007, Pages: 36
for several years, and many other countries are now following suit. Most significantly, payers in the United States are increasingly interested in the potential that HTA holds in reimbursement decision making
Cutting Edge Information, Aug 2009, Pages: 123
Reform in the United States
114 The Impact of European Healthcare Systems on Market Access Strategies Securing Market Access: Reimbursement, Payer Relationships and Healthcare Reform
Decision Resources, Inc., May 2010, Pages: 37
: - Issues affecting the pharmaceutical industry in the United States: key elements of healthcare reform legislation; prospects for improved access to health insurance; changes to Medicare; initiatives
Decision Resources, Inc., July 2010, Pages: 40
in Japan are generally marginally higher than European prices but lower than U.S.prices. How do drug prices in Japan compare overall with pharmaceuticalprices in the United States? To what extent do
Frost & Sullivan, Dec 2008, Pages: 75
in pricing and reimbursement approvals hinder the development of a competitive European generic pharmaceuticals industry.”
A consistent generics policy should be implemented across all European countries
